Coronary stents are medical devices used to treat narrowed or blocked coronary arteries, which can restrict blood flow to the heart. Companies involved in the development, manufacturing, and distribution of coronary stents play a crucial role in cardiovascular care.
Abbott Laboratories Received FDA approval for its Absorb Absorbable Heart stent system, a fully dissolving bioresorbable stent, offering a potential alternative to traditional metal stents.Continues to market its Xience V balloon expandable stent system, a leading product in the drug-eluting stent (DES) market.
Boston Scientific Corporation Launched its Promus Premier Elite DES with a new delivery system designed for improved visibility and control during PCI procedures.Acquired Tioga Medical, a company developing a balloon-expandable, bioresorbable stent, expanding its portfolio in this growing segment.
Medtronic Received FDA approval for its Resolute Onyxâ„¢ DES with a durable polymer coating designed for optimal drug delivery and long-term stent performance.Partnering with Philips Healthcare to develop and integrate artificial intelligence (AI) technology in coronary stent procedures for improved accuracy and efficiency.
Biotronik SE & Co. KG Launched its Orsiro DES with a unique biocompatible polymer and optimized stent design for enhanced tissue healing and reduced risk of in-stent thrombosis.Focusing on research and development of biodegradable polymer technologies for future generations of bioresorbable stents.
Terumo Corporation Received CE Mark approval for its DESolve DES, a fully bioresorbable stent system, making it available in the European market.Partnering with medical institutions to conduct clinical trials evaluating the performance of its DESolve stent in various patient populations.
List of Coronary Stent Key Companies in the Market
Coronary Stent Market Highlights:
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)